Varaico: Literature-Extracted Genetic Variants

Gene:TINF2
Variant:p.T284R
Back to variants list

TINF2

NM_001099274.3:p.T284R

Associated Papers

The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.

Tummala H et al.

Embo Molecular Medicine, 2024

39198715 (PubMed )
Supplement: 44321_2024_118_MOESM4_ESM.xlsx › Dataset_EV1

Digital telomere measurement by long-read sequencing distinguishes healthy aging from disease.

Sanchez SE et al.

Nature Communications, 2024

A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.

Villeneuve J et al.

American Journal of Respiratory Cell and Molecular Biology, 2024

Integrated proteogenomic analysis for inherited bone marrow failure syndrome.

Wakamatsu M et al.

Leukemia, 2024

38740980 (PubMed )
Supplement: 41375_2024_2263_MOESM2_ESM.xlsx › Table_S4

Digital telomere measurement by long-read sequencing distinguishes healthy aging from disease.

Sanchez SE et al.

Biorxiv : the Preprint Server for Biology, 2023

Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.

Choo S et al.

Blood, 2022

de Novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita.

Kocheva SA et al.

Balkan Journal of Medical Genetics : Bjmg, 2021

The molecular genetics of the telomere biology disorders.

Bertuch AA

Rna Biology, 2016

Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.

Alder JK et al.

Chest, 2015

Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2.

Vulliamy T et al.

Clinical Genetics, 2012

Molecular mechanisms of telomere biology disorders.

Grill S et al.

The Journal of Biological Chemistry, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."